News

FDA approves idelalisib for three leukemia and lymphoma indications
- Author:
- Elizabeth Mechcatie
Publish date: July 23, 2014
News

Study provides cancer risk estimates among women undergoing morcellation
- Author:
- Elizabeth Mechcatie
Publish date: July 22, 2014
Key clinical point: A study that provides an estimate of malignancies specifically among women undergoing morcellation and minimally invasive...
News

Study provides cancer risk estimates among women undergoing morcellation
- Author:
- Elizabeth Mechcatie
Publish date: July 22, 2014
Key clinical point: A study that provides an estimate of malignancies specifically among women undergoing morcellation and minimally invasive...
News

FDA approves C1-esterase inhibitor for hereditary angioedema
- Author:
- Elizabeth Mechcatie
Publish date: July 17, 2014
News

Viral reactivation common in septic patients
- Author:
- Elizabeth Mechcatie
Publish date: July 14, 2014
Key clinical point: Reactivation of latent viruses may underlie the development of sepsis in critically ill patients and contribute to their death...
News

FDA panel recommends informed consent, labeling changes to address morcellator risk
- Author:
- Elizabeth Mechcatie
Publish date: July 12, 2014
Video

VIDEO: ‘Improve – but do not abandon – power morcellation’
- Author:
- Elizabeth Mechcatie
Publish date: July 11, 2014
News
FDA panel addresses risks of power morcellators in fibroid surgery
- Author:
- Elizabeth Mechcatie
Publish date: July 11, 2014
News

FDA approves belinostat for peripheral T-cell lymphoma
- Author:
- Elizabeth Mechcatie
Publish date: July 8, 2014
News

FDA grants "breakthrough" status to investigational T-cell therapy for relapsed/refractory ALL
- Author:
- Elizabeth Mechcatie
Publish date: July 7, 2014
News

FDA grants "breakthrough" status to investigational T-cell therapy for relapsed/refractory ALL
- Author:
- Elizabeth Mechcatie
Publish date: July 7, 2014
News

FDA Approves Inhaled Insulin for Adults
- Author:
- Elizabeth Mechcatie
Publish date: June 27, 2014
News

FDA approves inhaled insulin for adults, with safety-monitoring plan
- Author:
- Elizabeth Mechcatie
Publish date: June 27, 2014
News

Phase III trial results needed before PARP inhibitor approved for ovarian cancer indication
- Author:
- Elizabeth Mechcatie
Publish date: June 26, 2014
News

FDA’s olmesartan probe showed no increased CV risk in diabetes
- Author:
- Elizabeth Mechcatie
Publish date: June 25, 2014